It has been well documented that human T cells that have been stimulated in unidirectional allogeneic mixed leukocyte cultures (MLC) may express surface antigens that are not detectable in resting T cells (1, 2) . For example, HLA-DR (or Ia) antigens have been demonstrated on the surface of >60% of MLC T cells, whereas <6% of normal T cells have been found to be positive for these markers (3) (4) (5) . Similarly, 4F2 antigen, a 120,000-mol wt protein normally found in peripheral blood monocytes (6) , is not detectable in resting T cells, but is expressed in MLC stimulated T cells (7, 8) .
Unlike resting T cells (9, 10), MLC-stimulated T cells can be propagated in vitro in the presence of interleukin 2 (IL-2) (11) . In addition, IL-2 has been used to derive functional T cell clones (12) (13) (14) . These clones express relatively large amounts of both Ia and 4F2 antigens irrespective of their functional activity (15) .
In this study, we analyzed whether Ia and/or 4F2 antigens were involved in IL-2dependent T cell proliferation. It will be shown that addition of D1/12 monoclonal antibody (Mab) directed against nonpolymorphic Ia determinants (16, 17) strongly inhibited IL-2 dependent proliferation of human MLC T cells and a cloned T cell line. In contrast, addition of anti-4F2 Mab had no effect on the proliferative response of human MLC or cloned T cells to IL-2. Moreover, addition of D1/12 Mab to murine MLC T cells, which do not express the determinants defined by D1/12 Mab, caused no inhibition of their proliferation induced by the same source of human IL-2.
Materials and Methods
Monodonal Antibodies. Derivation of the two hybridoma antibodies (Mab) used in the present study has been described previously (16, 17) . The anti-Ia DI/12 Mab is an IgG2 antibody directed to nonpolymorphic determinants of human Ia molecules; 4F2 Mab is an IgG2 antibody reacting against a 120,000-mol wt cell surface antigen expressed on peripheral blood monocytes and on activated T cells (7, 8) . The two monoclonals were used under the form of purified IgG at a dose of 10 #g/well unless otherwise specified.
Indicator Cell System. Human MLC T cells were obtained from unidirectional 7-d MLC containing 106 responding peripheral blood lymphocytes and 106 irradiated (5,000 rad) allogeneic cells as described previously (18) . T cells were purified according to their capacity to form spontaneous rosettes with sheep erythrocytes and stored frozen in liquid nitrogen until used. Clone 16 is a human T cell clone obtained from MLC T cells by limiting dilution techniques. The growth of clone 16 cells is dependent upon the presence of exogenous IL-2 in the culture medium. The cells grow without the presence of feeder cells, do not express Fc receptors for IgG, but express both Ia and 4F2 antigens. The functional properties as well as the surface phenotype of clone 16 cells have been described in a previous report (15) . Long-term MLC murine cells were obtained as described elsewhere (19) from 14-d MLC cultures containing C57BL/6 responding spleen cells and irradiated DBA/2 stimulating spleen cells.
Source of IL-2. Supernatants containing IL-2 activity were obtained from cultures of human spleen cells stimulated with phytohemagglutin (PHA) as described in detail elsewhere (20) . Supernatants were depleted of PHA by two-step sequential precipitation with 40 and 80%saturated ammonium sulphate (SAS) as previously described (21) . The 80% SAS-precipitated material was dialyzed and resuspended in a volume of RPMI 1640 medium corresponding to one half of the original culture volume.
Assay for IL-2 Activity. 104 indicator cells (human or mouse MLC cells and clone 16 cells)
were cultured for 72 h in RPMI 1640 medium (Gibco Bio-Ag, Basel Switzerland) supplemented with 10% fetal calf serum FCS (Gibco Bio-Ag) in round-bottomed microtiter trays (Greiner Labor Teeknik, Nurtingen, Germany). IL-2-containing medium was added at a final dilution of 1:2 (total volume 200 #1).
[3H]thymidine (TdR) was added (0.1/.tCi/well, sp act 9 mCi/mM) 6 h before harvesting the cultures. The uptake was determined according to Greaves et al. (22) . The counts per minute reported represent the mean value of triplicate cultures.
Results and Discussions
In a first series of experiments, 104 human MLC T cells were cultured with IL-2containing medium in the presence or absence of D1/12 or 4F2 hybridoma culture supernatant (final dilution, 1:20). Table I displays 
Effect of D1~12 Mab on the Proliferative Capacity of MLC T Cells in
Response to IL-2 parent myeloma PX63 culture supernatant (Table I) . Similar results were obtained in nine additional experiments involving different responder-stimulator cell combinations. Given (a) the ability of MLC T cell populations to mediate antibody-dependent lysis (23, 24) , and (b) the large proportion of MLC T ceils bearing Ia antigens, these results could have been explained by the killing of D 1/12 Mab-coated cells by effector cells present in the MLC populations. To rule out this possibility, we tested the effect of D1/12 Mab on II-2-induced proliferation of a cloned T cell line. As shown previously (15) , clone 16 cells do not bear Fc receptors for IgG, nor do they mediate antibody-dependent lysis. As assessed by flow cytofluorometry, Ia and 4F2 antigens are expressed in similar amounts on the surface of clone 16 cells (data not shown). As shown in Table II , the proliferation of clone 16 cells in the presence of IL-2 was markedly inhibited in cultures containing D 1/12 Mab, but was unaffected in cultures containing 4F2 Mab or PX63 culture supernatant.
Because these results indicated that inhibition of proliferation by D1/12 Mab was not caused by antibody-dependent cell-mediated lysis of Ia + T cells, we then considered the possibility that D1/12 Mab could functionally inactivate the human IL-2 preparation used in this study. If this was the case, the inhibitory effect of D1/12 Mab on IL-2-induced proliferation would be exerted independently of the presence of Ia antigens on IL-2-responding T cell populations.
Because human IL-2 has been shown to be active on murine T cells (25), we used long-term C57BL/6 anti-DBA/2 MLC cells (19) as a source of IL-2-responding T cells. These cells, after 3 d of culture in the presence of human IL-2, exhibit a strong proliferative response upon reexposure to human IL-2 (Table III) * 100 /xl of human IL-2-containing medium was added to 100 /xl of culture medium containing 104 murine MLC cells derived from C57BL/6 anti-DBA/2 long-term MLC as described previously (19) . $ As in Table I. § As in Table 1 .
not react with D1/12 Mab as assessed by quantitative immunofluorescence and complement-dependent lysis (data not shown). Table III shows that addition of D1/12 Mab to cultures of murine MLC cells had no effect on human IL-2-indueed proliferation.
Further evidence that D1/12 Mab did not react with human IL-2 was provided by the demonstration that IL-2-containing supernatants that had been twice passed through an immunoadsorbent column of D1/12 Mab coupled-Sepharose beads showed no decrease in IL-2 activity (data not shown).
These experiments clearly indicate that the inhibition of IL-2-induced proliferation of human MLC-T cells is a consequence of a direct interaction of D1/12 Mab with surface Ia molecules. The precise mechanism(s) by which anti-Ia Mab inhibits T cell proliferation has still to be determined. Several possibilities can be envisaged: (a) Anti-Ia Mab may inhibit the binding of IL-2 to the corresponding surface receptors by steric hindrance. Previous studies have shown that D1/12 Mab reacts with a specific subset of human Ia antigens accounting for only a portion of the human Ia molecular pool (16, 17) . Therefore, if the above mentioned mechanism is correct, one should envisage a topographic close association between IL-2 receptors and this limited portion ofla molecules. (b) Ia molecules may participate in the cellular events required for the transmission of the signal(s) given by IL-2 and resulting in cell proliferation. Studies are in progress in our laboratory to discriminate between these or other possibilities.
Summary
We have studied the effect on the interleukin (IL-) 2-dependent human T cell growth of two distinct monoclonal antibodies (Mab), D1-12 and 4F2, with specificity for common determinant of human Ia antigens and for a differentiation antigen expressed on all activated T cells, respectively. Strong inhibition of cell growth was found in cultures supplemented with the anti-Ia Dl-12 Mab but not in cultures supplemented with 4F2 Mab. These results were obtained when either total mixed leukocyte culture (MLC) T cells or an MLC-derived T cell clone were used as indicator cell systems for IL-2 activity.
The inhibition of cell growth appears to be mediated by a direct interaction of D 1-12 Mab with the cells and not by a direct inactivation of the growth factor, as addition of the antibody to murine MLC T cells, which do not express the determinant defined by D1-12 Mab, resulted in no inhibition of their proliferation induced by the same source of human IL-2.
